Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Keri L. Calkins"'
Publikováno v:
BMC Medical Research Methodology, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Restricted mean survival time (RMST) is an underutilized estimand in time-to-event analyses. Herein, we highlight its strengths by comparing time to (1) all-cause mortality and (2) initiation of antiretroviral therapy (ART) for HI
Externí odkaz:
https://doaj.org/article/a523470c09ef4744816c6848b02bb808
Publikováno v:
Health Services Research.
Autor:
Anthony T Fojo, Catherine R. Lesko, Geetanjali Chander, Richard D. Moore, Corinne E. Joshu, Keri L. Calkins, Kala Visvanathan, Bryan Lau
Publikováno v:
Cancer Causes Control
PURPOSE: A comparison of stage at cancer diagnosis and cancer treatment rates between people with HIV (PWH) and the general US population is needed to identify any disparities by HIV status. METHODS: We compared 236 PWH in clinical care diagnosed wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbaa7cb1253353c99a4386d7a918b86b
https://europepmc.org/articles/PMC7416538/
https://europepmc.org/articles/PMC7416538/
Autor:
William C. Mathews, Bryan Lau, Brian W. Pence, Michael J. Mugavero, Katerina A. Christopoulos, Mary E. McCaul, Catherine R. Lesko, Heidi E. Hutton, Anthony T Fojo, Geetanjali Chander, Karen L. Cropsey, Richard D. Moore, Heidi M. Crane, Keri L. Calkins, Kenneth H. Mayer
Publikováno v:
AIDS and behavior, vol 23, iss 3
INTRODUCTION: Few studies examine how depression and substance use interact to affect HIV control. METHODS: In 14,380 persons with HIV (PWH), we used logistic regression and generalized estimating equations to evaluate how symptoms of depression inte
Autor:
Geetanjali Chander, Richard D. Moore, Kala Visvanathan, Bryan Lau, Catherine R. Lesko, Anthony T Fojo, Corinne E. Joshu, Keri L. Calkins
Publikováno v:
AIDS Res Hum Retroviruses
A total of 236 people with HIV (PWH) with cancer diagnosed between 1997 and 2014 in the Johns Hopkins HIV Clinical Cohort (JHHCC) were compared with a sample from NCI's Surveillance, Epidemiology, and End Results (SEER) Program, presumed to be HIV ne
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:PO-179
Background: Studies suggest women living with HIV (WHIV) may have lower breast cancer incidence compared to the general population. To minimize the effect of potential differences in the prevalence of risk factors for breast cancer incidence and dete
Autor:
Catherine R. Lesko, Geetanjali Chander, Corinne E. Joshu, Keri L. Calkins, Bryan Lau, Richard D. Moore, Kala Visvanathan, Anthony T Fojo
Publikováno v:
JAMA Oncology. 6:227
Importance Immunologic decline associated with cancer treatment in people with HIV is not well characterized. Quantifying excess mortality associated with cancer treatment–related immunosuppression may help inform cancer treatment guidelines for pe
Autor:
Adrienne Tin, Michelle M. Estrella, Lisa P. Jacobson, Long Zhang, Frank J. Palella, Keri L. Calkins, Lawrence A. Kingsley, Todd T. Brown, Andrew N. Hoofnagle, Mallory D. Witt, Alison G. Abraham
Publikováno v:
AIDS (London, England). 32(8)
OBJECTIVE: Despite effective antiretroviral therapy (HAART) and durable viral suppression, many HIV-infected individuals still do not achieve CD4+ cell count (CD4) normalization. Vitamin D has immunoregulatory functions, including inducing the develo
Publikováno v:
BMC Medical Research Methodology
BMC Medical Research Methodology, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Medical Research Methodology, Vol 18, Iss 1, Pp 1-10 (2018)
Background Restricted mean survival time (RMST) is an underutilized estimand in time-to-event analyses. Herein, we highlight its strengths by comparing time to (1) all-cause mortality and (2) initiation of antiretroviral therapy (ART) for HIV-infecte
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 77(3)
BACKGROUND: The inflammatory effects of injection drug use may result in an impaired immune response to antiretroviral therapy (ART). We examined CD4 response to first ART regimen among individuals in routine HIV care, stratified by injection drug us